Skip to main content

and
  1. Article

    Open Access

    MRI morphological characteristics of lymph nodes in anal squamous cell carcinoma

    Pre-treatment staging of anal squamous cell carcinoma (ASCC) includes pelvic MRI and [18F]-fluorodeoxyglucose positron emission tomography with computed tomography (PET-CT). MRI criteria to define lymph node m...

    Stephanie Gulevski, Anna Frennered, Elin Trägårdh, Martin P. Nilsson in Abdominal Radiology (2024)

  2. Article

    Open Access

    Pelvic U-Net: multi-label semantic segmentation of pelvic organs at risk for radiation therapy anal cancer patients using a deeply supervised shuffle attention convolutional neural network

    Delineation of organs at risk (OAR) for anal cancer radiation therapy treatment planning is a manual and time-consuming process. Deep learning-based methods can accelerate and partially automate this task. The...

    Michael Lempart, Martin P. Nilsson, Jonas Scherman in Radiation Oncology (2022)

  3. Article

    Open Access

    Genetic testing in women with early-onset breast cancer: a Traceback pilot study

    In Sweden, a Traceback approach, i.e., a retrospective genetic outreach activity, among cancer patients is not normally used in clinical practice. In this pilot study, we wanted to evaluate a Traceback strateg...

    Annelie Augustinsson, Martin P. Nilsson in Breast Cancer Research and Treatment (2021)

  4. Article

    Open Access

    Sarcopenia and dosimetric parameters in relation to treatment-related leukopenia and survival in anal cancer

    Treatment-related white blood cell (WBC) toxicity has been associated with an inferior prognosis in different malignancies, including anal cancer. The aim of the present study was to investigate predictors of ...

    Martin P. Nilsson, Anders Johnsson, Jonas Scherman in Radiation Oncology (2021)

  5. Article

    Open Access

    Patterns of pathologic lymph nodes in anal cancer: a PET-CT-based analysis with implications for radiotherapy treatment volumes

    This study investigates the patterns of PET-positive lymph nodes (LNs) in anal cancer. The aim was to provide information that could inform future anal cancer radiotherapy contouring guidelines.

    Anna Frennered, Jonas Scherman, Pamela Buchwald, Anders Johnsson in BMC Cancer (2021)

  6. Article

    Open Access

    Breast cancer survival in Nordic BRCA2 mutation carriers—unconventional association with oestrogen receptor status

    The natural history of breast cancer among BRCA2 carriers has not been clearly established. In a previous study from Iceland, positive ER status was a negative prognostic factor. We sought to identify factors tha...

    Elinborg J. Olafsdottir, Ake Borg, Maj-Britt Jensen in British Journal of Cancer (2020)

  7. Article

    Open Access

    Patterns of recurrence in anal cancer: a detailed analysis

    Anal cancer is a rare disease, which might be the reason for the “one size fits all” approach still used for radiotherapy target contouring. To refine and individualize future guidelines, detailed and contempo...

    Martin P. Nilsson, Erik D. Nilsson, Anders Johnsson, Otilia Leon in Radiation Oncology (2020)

  8. Article

    Open Access

    High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study

    In the BRCAsearch study, unselected breast cancer patients were prospectively offered germline BRCA1/2 mutation testing through a simplified testing procedure. The purpose of the present study was to evaluate sat...

    Martin P. Nilsson, Erik D. Nilsson, Åke Borg in Breast Cancer Research and Treatment (2019)

  9. Article

    Open Access

    Germline mutations in BRCA1 and BRCA2 incidentally revealed in a biobank research study: experiences from re-contacting mutation carriers and relatives

    Once an incidental finding (IF) is discovered in the course of genomic research, the researchers are faced with the question of whether or not that finding should be reported back to the study participant. A l...

    Martin P. Nilsson, Monica Emmertz, Ulf Kristoffersson in Journal of Community Genetics (2018)

  10. Article

    Open Access

    BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer

    To evaluate a simplified method of pre-test information and germline BRCA1/2 mutation testing.

    Martin P. Nilsson, Therese Törngren in Breast Cancer Research and Treatment (2018)

  11. Article

    Open Access

    Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer

    Increasing evidence supports the benefit of identifying BRCA1 and BRCA2 germline mutations in early breast cancer. Selection of patients for genetic testing is based on defined criteria taking individual and fami...

    Martin P. Nilsson, Christof Winter, Ulf Kristoffersson, Martin Rehn in Familial Cancer (2017)

  12. Article

    Open Access

    Comparison of doses and NTCP to risk organs with enhanced inspiration gating and free breathing for left-sided breast cancer radiotherapy using the AAA algorithm

    The purpose of this study was to investigate the potential dose reduction to the heart, left anterior descending (LAD) coronary artery and the ipsilateral lung for patients treated with tangential and locoregi...

    Anneli Edvardsson, Martin P Nilsson, Sousana Amptoulach, Sofie Ceberg in Radiation Oncology (2015)

  13. Article

    Open Access

    High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer

    The purpose of the study was to compare breast-conserving therapy (BCT) and mastectomy (M) in BRCA1/2 mutation carriers. Women with invasive breast cancer and a pathogenic mutation in BRCA1 or BRCA2 were included...

    Martin P. Nilsson, Linda Hartman in Breast Cancer Research and Treatment (2014)

  14. Article

    Open Access

    Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status

    All women in the South Sweden Health Care Region with breast cancer diagnosed aged less than 41 during the period between 1990 and 1995 were contacted in 1996 and offered germline mutation analysis of the BRCA1 a...

    Martin P. Nilsson, Linda Hartman, Ingrid Idvall in Breast Cancer Research and Treatment (2014)